uniQure N.V. (NASDAQ: QURE) Faces Legal Challenges Amid Financial Struggles

uniQure N.V. (NASDAQ:QURE) anticipates a quarterly loss of $0.93 per share with projected revenue of $4.7 million.The company is involved in a class action lawsuit for alleged securities law violations, potentially impacting its financial performance.Financial metrics reveal a negative P/E ratio of -4.26 and a high price-to-sales ratio of 66.94, indicating financial challenges.uniQure N.V. (NASDAQ:QURE), a biotechnology company known for its focus on gene therapy, is set to release its quarterly earnings on ...